FTLP14

Across TCGA pan-cancer cohorts, FTLP14 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated FTLP14 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher FTLP14 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated FTLP14 expression acts as an unfavorable survival marker, although some lineages such as KICH and BLCA show a favorable association.

KICH, BLCA, and LGG are the cancer types where FTLP14 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Quartile	II,III,IV	1.000	0.242	.002	102	view →
BLCA	OS	Median	II,III,IV	0.540	0.344	<.001	50	view →
LGG	DFS	Median	All	0.661	0.805	<.001	47	view →
ESCA	DFS	Median	All	0.279	0.914	.002	41	view →
UVM	DFS	Quartile	All	0.413	0.869	<.001	34	view →
KIRC	DFS	Quartile	II,III,IV	0.658	0.446	.012	30	view →
SKCM	OS	Tertile	III,IV	0.287	0.545	.005	21	view →
KIRP	DFS	Quartile	II,III,IV	0.215	0.855	.005	20	view →
LUAD	DFS	Median	IV	0.332	0.761	.002	18	view →
THCA	OS	Median	II,III,IV	0.958	0.996	.008	17	view →
PRAD	DFS	Median	All	0.963	0.904	<.001	16	view →
READ	OS	Tertile	II,III,IV	0.562	0.964	.011	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

FTLP14–KICH (DFS)

Open the KICH breakdown →